Max Rubinson

• Representing a global animal health company in an international arbitration involving breach of contract claims.
• Representing a global animal health company in litigation in the Delaware Chancery Court involving breach of contract and tortious interference claims.
• Representing a global animal health company in patent litigation in the District of New Jersey involving patents related to vaccines for preventing porcine circovirus infection in piglets.
• Representing a global animal health company in inter partes review proceedings before the USPTO involving patents related to vaccines for preventing porcine circovirus infection in piglets.
• Representing a global flooring manufacturer in an ITC investigation involving patents related to luxury vinyl tile products.
• Representing a global financial technology company in patent litigation in the Northern District of Ohio involving patents related to ATM components.
• Representing a global consumer products company in patent litigation in the Central District of California involving patents related to diaper disposal systems.
• Representing a global telecommunications company in an ITC investigation involving patents related to subsea cable systems.
• Represented a global pharmaceutical company in ANDA litigation in the District of New Jersey involving patents related to opioids.
• Represented a global pharmaceutical company in ANDA litigation in the District of Delaware involving patents related to topical steroid compounds for eczema.
• Represented a major U.S. animal health company in litigation in the Northern District of California involving false advertising claims related to glucosamine supplements.
• Represented a global footwear company in patent litigation in the District of Delaware involving patents related to golf shoes.
• Represented a global animal health company in an interference proceeding before the USPTO involving patents related to flea and tick medications.

Max Rubinson is an associate in the Intellectual Property Litigation Group and a member of the Biotechnology, Pharmaceutical & Life Sciences Patent Litigation Team. He has experience litigating intellectual property cases throughout the U.S., particularly in the animal health and pharmaceutical spaces. He has been involved in patent cases covering diverse areas of technology, including pharmaceuticals, animal health products, telecommunications systems, and consumer products. Max also has experience representing clients in trademark, false advertising, and unfair competition cases brought under the Lanham Act.

Max has represented clients in federal courts across the country and before the International Trade Commission (ITC), International Chamber of Commerce (ICC) International Court of Arbitration, and U.S. Patent and Trademark Office (USPTO).

Max received his J.D. from Emory University School of Law, with honors, in 2017. While in law school, he served as the executive articles editor of the Emory International Law Review. He received his B.S. in chemistry from Emory University in 2010. Max also received an M.A. in biochemistry from the University of Texas at Austin in 2013.

Bar Admissions

• Georgia

Education

• Emory University (J.D., 2017)
• University of Texas at Austin (M.A., 2013)
• Emory University (B.S., 2010)